Saltar al contenido

Boston Scientific Corp (BSX) stock: revenue, earnings & dividend

Boston Scientific Corp (BSX, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener BSX · NYSE Medizintechnik & Messgeräte US-MA

Key figures

Fiscal year
2025
Revenue
20.1 bn $
Revenue growth
19.9 %
Revenue growth 5y (p.a.)
15.2 %
Net income
–
Net margin
–
Operating margin
18 %
Earnings per share (diluted)
1.94 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
43.7 bn $
Equity
24.2 bn $
Equity ratio
55.5 %
Return on equity
–
Cash
1.97 bn $
Operating cash flow
4.53 bn $
Free cash flow
3.66 bn $
Shares outstanding
1,449,473,222

History

Revenue by fiscal year

2016 9.08 bn $
2017 9.05 bn $
2018 9.82 bn $
2019 10.7 bn $
2020 9.91 bn $
2021 11.9 bn $
2022 12.7 bn $
2023 14.2 bn $
2024 16.7 bn $
2025 20.1 bn $

Net income by fiscal year

YearRevenueNet incomeEPSDividend per shareOperating cash flow
202520.1 bn $–1.94 $–4.53 bn $
202416.7 bn $–1.25 $–3.44 bn $
202314.2 bn $–1.07 $–2.5 bn $
202212.7 bn $–0.45 $–1.53 bn $
202111.9 bn $–0.69 $–1.87 bn $
20209.91 bn $–-0.08 $–1.51 bn $
201910.7 bn $–3.33 $–1.84 bn $
20189.82 bn $–1.19 $–310 m $
20179.05 bn $–0.08 $–1.43 bn $
20169.08 bn $–0.25 $–1.18 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)